Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan
Clinical trial NCT05153187 · COMPLETED
Trial details
- NCT number
- NCT05153187
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-31
- Primary completion
- 2021-06-30
- Enrollment
- 1170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.